Landscapes / Companies
Poseida Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 1
Drugs
3
in active trials · 5 in all
Trials
4 active
6 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Mar 2029Phase 1 trial completes | |||
| Next date | Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2029Phase 1 trial completes | |||
| Next date | Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma and 8 more | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2039Phase 1 trial completes | |||
| Next date | Apr 2039 · Phase 1 trial completes | ||||
| Also tested for | Breast Cancer, Ovarian Cancer and 7 more | ||||
| Open drug page | |||||
About
- No active trial
- P-BCMA-101 CAR-T cells, P-PSMA-101 CAR-T cells
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021